COMBINATION CHEMOTHERAPY WITH VP 16-213 IN L1210 LEUKEMIA

被引:0
|
作者
DOMBERNOWSKY [1 ]
NISSEN, NI [1 ]
机构
[1] FINSEN INST,COPENHAGEN,DENMARK
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:167 / 167
页数:1
相关论文
共 50 条
  • [41] NUCLEOSIDE KINASES IN LEUKEMIA L1210
    SCHRECKER, AW
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1969, 10 (MAR): : 77 - +
  • [42] CHEMOTHERAPY OF L1210 AND L1210/ARA-C LEUKEMIA WITH 5-AZA-2'-DEOXYCYTIDINE AND 3-DEAZAURIDINE
    MOMPARLER, RL
    MOMPARLER, LF
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 25 (01) : 51 - 54
  • [43] EPIPODOPHYLLOTOXIN (VP 16-213) IN DISSEMINATED HISTIOCYTIC LYMPHOMA - PILOT-STUDY
    JACOBS, P
    KING, H
    SEALY, R
    SOUTH AFRICAN MEDICAL JOURNAL, 1975, 49 (26): : 1056 - 1057
  • [44] DETERMINATION OF 2 HYDROPHYLIC METABOLITES OF THE ANTINEOPLASTIC AGENT ETOPOSIDE (VP 16-213)
    HOLTHUIS, JJM
    VANOORT, WJ
    HULSHOFF, A
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1985, 7 (06) : 289 - 289
  • [45] COMPARATIVE KINETICS AND CHEMOTHERAPY OF SLOW GROWING B16 MELANOMA AND FAST GROWING L1210 LEUKEMIA
    WODINSKY, I
    VENDITTI, JM
    KENSLER, CJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1972, 13 (MAR): : 8 - &
  • [46] CHEMOTHERAPY OF L1210 LEUKEMIA WITH 5-AZACYTIDINE IN COMBINATION WITH VINCRISTINE, ADRIAMYCIN, OR BETA-CYTOSINE ARABINOSIDE
    PRESANT, CA
    VIETTI, TJ
    VALERIOTE, F
    COULTER, DM
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1981, 67 (06) : 1283 - 1288
  • [47] ANALYSIS AND DEGRADATION KINETICS OF ETOPOSIDE (VP 16-213) IN AQUEOUS-SOLUTION
    UNDERBERG, WJM
    KERKDIJK, HG
    HOLTHUIS, JJM
    BEIJNEN, JH
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1985, 7 (06) : 291 - 291
  • [48] CLINICAL EXPERIENCE WITH NEW EPIPODOPHYLLOTOXIN VP 16-213 IN TREATMENT OF HUMAN NEOPLASMS
    JUNGI, WF
    SENN, HJ
    BECKMANN, C
    FLURY, R
    FREI, P
    HOLDENER, E
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1975, 105 (42) : 1365 - 1369
  • [49] Enhancement of leukemia rejection by mice successfully treated for L1210 leukemia due to low dose compared to high dose VP-16
    Slater, LM
    Stupecky, M
    Sweet, P
    Osann, KE
    LEUKEMIA RESEARCH, 2002, 26 (02) : 203 - 206
  • [50] VP 16-213 COMBINED WITH CYCLOPHOSPHAMIDE, METHOTREXATE AND VINCRISTINE IN POLYCHEMOTHERAPY OF BRONCHOGENIC CARCINOMA
    RYSSEL, HJ
    HASLER, E
    SONNTAG, RW
    CAVALLI, F
    MARTIN, J
    TSCHOPP, L
    BRUNNER, KW
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1977, 107 (26) : 912 - 915